Post by
Ingiboy on Oct 22, 2023 11:03am
Week 2
What can we expect in week 2 of the "post Arbitration" era. Week 1 was surprsingly benign. A little volume from the panickers but after that little volume and the share price flat lined.
What is needed in week 2 is the plan.
How does Replicel move forward ? I imagine Andrew and his Directors have met and discussed what now needs to be done.
For sure it involves accelerating the development and approval of the Dermal Injector. It is the closest asset that can be taken to commercialization and revenue generation. This will have to include financial support from Mainpointe. This will signal to the market that Replicel is still a viable company
Comment by
Ingiboy on Oct 23, 2023 8:35pm
Well, I thought today would be the day for The Plan but maybe there isn't a Plan. After a week you woud have thought the Directors woud release some kind of N/R bringing us up to date but when you see nothing you begin to think the future of Replicel is bleak at best. Oh well we press on.